Lake Street analyst Thomas Flaten maintained a Buy rating on DermTech (DMTK – Research Report) today and set a price target of $4.50. The company’s shares closed yesterday at $1.40. According to ...
In a report released yesterday, Mark Massaro from BTIG maintained a Buy rating on DermTech (DMTK – Research Report), with a price target of $4.00. The company’s shares closed last Friday at $1.75.
NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK). Such investors are advised to ...
SAN DIEGO, CA, USA, November 20, 2023 /EINPresswire.com/ -- Reminder About DMTK Class Action: Shareholders Should Contact Robbins LLP for Information About the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results